Jefferies Comments On Dentsply Revised Forecasts

According to Jefferies, Dentsply (NASDAQ: XRAY) price target is moved to $44.

Jefferies said that its price target moves to $44 (from $42) on greater confidence in XRAY's ability to mitigate the near-term financial impact of disruption to its Japanese supplier. “Our $44 PT represents a 10-year horizon in our DCF model and implies an EV of 12.0x our 2012 EBITDA forecast. Risks: greater dislocation from Japanese supplier, weakness in Lab.”

Dentsply closed yesterday at $38.01.